D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression
Clinical trial NCT02772211 · UNKNOWN
Trial details
- NCT number
- NCT02772211
- Sponsor
- Sheba Medical Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2016-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.